光量子治疗原发性高血压患者钠钾ATP酶改变的实验研究  

Examing studing of ATP - Exzyme change in Patient with Primary Hypertenion by Quantum - ray

作　　者：孙红军[1] 李英[1] 李永军 

机构地区：[1]山东省德州市人民医院,253014 [2]山东省德州市武警医院,253014

出　　处：《实用医技杂志》2000年第9期643-644,共2页Journal of Practical Medical Techniques

摘　　要：光量子治疗原发性高血压临床虽取得比较满意的效果,但其降压机制未明。红细胞膜钠钾ATP活性变化,作为原发性高血压发病机制之一已得到认可。本文从检测红细胞膜ATP酶活性入手,观察30例原发性高血压患者于光量子治疗前后_ATP酶活性的改变及血压的改变,以探讨光量子治疗原发性高血压其疗效机制与光量子对红细胞膜ATP酶活性的影响有关。The article has been reported that the clinical effect was satisfied of Patient with Primary hypertension by Quantum- ray. Although the mechanism of it was not determine the Na+-K+ ATP exzyme change in RBC was one of the mechanism in primary hypertension. Through ATP-exzyme and blood- Pressure change of 30 cases with Primary hypertension by Quantum -ray. it was raised that the treatment mechanism of Primary hypertension was related to ATP-exzyme change in RBC by Quantum -ray.

关 键 词：原发性高血压 钠钾ATP酶 光量子疗法 

分 类 号：R544.1[医药卫生—心血管疾病]